ChemGenex Pharmaceuticals (CXS)

Stock Code


Stock Exchange


ChemGenex Pharmaceuticals (CXS) is an Australia-based biotechnology research and development company engaged in the improving patients' lives through the development of personalised therapeutics in the areas of obesity, cancer, depression and diabetes. CXS was listed on the 10th of July 1986. Its average annual revenue reaches approximately $1 million. Its head office is located in Victoria, Australia and to date; around 40 people are employed in the company. ChemGenex Pharmaceuticals Ltd maintains three key drugs: Quinamed, Ceflatonin and CXS-299.

ChemGenex Pharmaceuticals Dividends

1 September, 2010 - 13:29

Peruse the dividend history for CHEMGENEX PHARMACEUTICALS LTD. Dividends are a portion of company profits paid out to shareholders. You are eligible to receive CXS dividends if you own the CHEMGENEX PHARMACEUTICALS LTD shares on the ex-dividend date. Traders and investors must purchase the stock before the exdividend date to be entitled to the dividend. The previous owner of the shares will receive the CXS dividend if you buy the stocks on or after the ex dividend date.

ChemGenex Shares Takes a Hit due to Misunderstanding

ChemGenex Pharmaceuticals (CXS), an Australia based biotechnology research and development company that develops leukemia drugs stated that the latest difficulties faced by the company with the Food and Drug Administration (FDA) is only another hurdle in the drug approval process, although the traders provided the ChemGenex stocks with a right old shellacking.

Syndicate content

Recommended Websites